Siddhartha Mukherjee

Siddhartha Mukherjee (born 21 July 1970)[1] is an Indian-American physician, biologist, oncologist, and author. He is best known for his 2010 book, The Emperor of All Maladies: A Biography of Cancer that won notable literary prizes including the 2011 Pulitzer Prize for General Non-Fiction,[2] and Guardian First Book Award,[3] among others. The book was listed in the "All-Time 100 Nonfiction Books" (the 100 most influential books of the last century) by Time magazine in 2011.[4] His 2016 book The Gene: An Intimate History made it to #1 on The New York Times Best Seller list,[5] and was among The New York Times 100 best books of 2016,[6] and a finalist for the Wellcome Trust Prize and the Royal Society Prize for Science Books.

Siddhartha Mukherjee
Mukherjee in 2017
Born (1970-07-21) 21 July 1970
New Delhi, India
CitizenshipUnited States
Alma mater
Known for
Spouse(s)Sarah Sze
Children2
AwardsRhodes Scholarship
Pulitzer Prize for General Non-Fiction (2011)
Guardian First Book Award (2011)
Padma Shri (2014)
Scientific career
FieldsImmunology
Cancer epidemiology
Genetic epidemiology
InstitutionsColumbia University
ThesisThe processing and presentation of viral antigens (1997)
Websitesiddharthamukherjee.com

After completing school education in India, Mukherjee studied biology at Stanford University, obtained a D.Phil. from University of Oxford as a Rhodes Scholar, and an M.D. from Harvard University. He joined NewYork–Presbyterian Hospital / Columbia University Medical Center in New York City in 2009. As of 2018, he is an Associate Professor of Medicine in the Division of Hematology and Oncology.[7]

Featured in the Time 100 list of most influential people, Mukherjee writes for The New Yorker and is a columnist in The New York Times. He is described as part of a select group of doctor-writers (such as Oliver Sacks and Atul Gawande) who have "transformed the public discourse on human health",[8] and allowed a generation of readers a rare and intimate glimpse into the life of science and medicine.[9] His research concerns the physiology of cancer cells, immunological therapy for blood cancers, and the discovery of bone- and cartilage-forming stem cells in the vertebrate skeleton.[10]

The Government of India conferred on him its fourth highest civilian award, the Padma Shri, in 2014.[11]

Early life and education

Siddhartha Mukherjee was born to a Bengali family in New Delhi, India. His father, Sibeswar Mukherjee, was an executive with Mitsubishi, and his mother Chandana Mukherjee, was a former school teacher from Calcutta (now Kolkata). He attended St. Columba's School in Delhi, where he won the school's highest award, the 'Sword of Honour', in 1989. As a biology major at Stanford University, he worked in Nobel Laureate Paul Berg's laboratory, defining cellular genes that change the behaviours of cancer cells. He earned membership in Phi Beta Kappa[12] in 1992, and completed his Bachelor of Science (B.S.) degree in 1993.[1]

Mukherjee won a Rhodes Scholarship for doctoral research at Magdalen College, University of Oxford. He worked on the mechanism of activation of the immune system by viral antigens. He was awarded a D.Phil. in 1997 for his thesis titled The processing and presentation of viral antigens.[13] After graduation, he attended Harvard Medical School, where he earned his Doctor of Medicine (M.D.) degree in 2000.[14] Between 2000 and 2003 he worked as a resident in internal medicine at the Massachusetts General Hospital. From 2003 to 2006 he trained in oncology as a Fellow at the Dana-Farber Cancer Institute (under Harvard Medical School) in Boston, Massachusetts.[15][16]

Career

In 2009, Mukherjee joined the faculty of the Department of Medicine in the Division of Hematology/Oncology at the Columbia University Medical Center as an Assistant Professor.[1][17] The medical center is attached to the NewYork-Presbyterian Hospital in New York City.[18]

He was previously affiliated with the Harvard Stem Cell Institute and with Massachusetts General Hospital in Boston. He has worked as the Plummer Visiting Professor at the Mayo Clinic in Rochester, Minnesota, the Joseph Garland lecturer at the Massachusetts Medical Society, and an honorary visiting professor at Johns Hopkins School of Medicine.[19] His laboratory is based at Columbia University's Herbert Irving Comprehensive Cancer Center.[20]

Contributions

Cancer research

Mukherjee is a trained haematologist and oncologist whose research focuses on the links between normal stem cells and cancer cells. Through his findings, he had shown the roles of cells in cancer therapy.[21] He has been investigating the microenvironment ("niche") of stem cells, particularly on blood-forming (haematopoietic) stem cells. Blood-forming stem cells are present in the bone marrow in very specific microenvironments. Osteoblasts, cells that form bone, are one of the principal components in this environment. These cells regulate the process of blood cell formation and development by providing them with signals to divide, remain quiescent, or maintain their stem cell properties.[22] Distortion in the development of these cells results in severe blood cancers, such as myelodysplastic syndrome and leukemia.[23] Mukherjee's research has been recognised through many grants from the National Institutes of Health and from private foundations.[10][24][25]

Mukherjee and his co-workers have identified several genes and chemicals that can alter the microenvironment, or niche, and thereby alter the behavior of normal stem cells, as well as cancer cells.[26][27][28][29][30][31] Two such chemicals – proteasome inhibitors[26] and activin inhibitors[32] – are under clinical trials.[33][34] Mukerjee's lab has also identified novel genetic mutations in myelodysplasia and acute myelogenous leukaemia and has played a leading role in finding therapies for these diseases.[35][36]

Bone formation

Mukherjee's team is also known for defining and characterizing skeletal stem/progenitor cells (also called osteochondroreticular or OCR cells). In 2015, they prospectively identified these progenitor cells from bone, and showed, using lineage tracing, that these cells can give rise to bone, cartilage, and reticular cells (hence the term "OCR" cells). They established that these cells form a part of the adult skeleton in vertebrates, and that they maintain and repair the skeleton.[37]

OCR cells are among the newest progenitor cells to be defined in vertebrates.[38] The work generated wide interest and was described in prominent journals as a major breakthrough for understanding biology and for understanding diseases such as osteoporosis and osteoarthritis.[39][40] Mukherjee's team have shown that OCR cells can be transplanted into animals, and they can regenerate cartilage and bone after fractures.[37] With Daniel L. Worthley's team at the University of Adelaide and South Australian Health and Medical Research Institute they have been working on the translational cell-based research on osteoarthritis and cancer.[37][41]

Metabolic therapies for cancer

Mukherjee's lab has also been investigating the interaction between cancer genetics and the microenvironment, including the metabolic environment. It has been well established that metabolism in cancer is fundamentally altered,[42] Mukherjee's team has found the role of a high-fat, adequate-protein, low-carbohydrate diet (ketogenic diet) in cancer therapy. They showed that ketogenic diet suppressed insulin production in the body, and this in turn enhances pharmaceutical inhibition of PIK3CA, a gene which is mutated and commonly overactive in cancers.[43]

Immune therapies for acute leukemia

Mukherjee's lab, with the help of PureTech Health plc, has been investigating chimeric antigen receptor redirected T cells (CAR-T) therapy in a joint venture called Vor BioPharma since 2016.[44] They have combined CAR-T therapies with genetically modified hematopoietic stem cells to specifically target malignant hematopoietic lineages, while transplanted stem cells replenish the lineage but remain antigenically concealed. This technology has been developed so that, in addition to B cell malignancies, other lineage specific cancers could be targeted.[45] This provides an important new approach to managing acute myeloid leukemia.[46]

Books

In 2010, Simon & Schuster published his book The Emperor of All Maladies: A Biography of Cancer[47] detailing the evolution of diagnosis and treatment of human cancers from ancient Egypt to the latest developments in chemotherapy and targeted therapy.[48] On 18 April 2011, the book won the annual Pulitzer Prize for General Non-Fiction; the citation called it "an elegant inquiry, at once clinical and personal, into the long history of an insidious disease that, despite treatment breakthroughs, still bedevils medical science."[49] It was listed in the "All-Time 100 Nonfiction Books" (the 100 most influential books of the last century)[4] and the "Top 10 Nonfiction Books of 2010" by Time in 2011.[50] It was also listed in "The 10 Best Books of 2010" by The New York Times[51] and "Top 10 Books of 2010" by O, The Oprah Magazine.[52] In 2011, it was nominated as a National Book Critics Circle Award finalist.[53]

Based on the book, Ken Burns made a PBS Television documentary film Cancer: The Emperor of All Maladies in 2015,[54] which was nominated for an Emmy Award.[55]

Mukherjee's 2016 book The Gene: An Intimate History provides a history of genetic research, but also delves into the personal genetic history of the author's family, including mental illness. The book discusses the power of genetics in determining people's health and attributes, but it also has a cautionary tone to not let genetic predispositions define fate, a mentality that led to the rise of eugenics in history and something he thinks lacks the nuance required to understand something as complex as human beings. The Gene was shortlisted for the Royal Society Insight Investment Science Book Prize 2016, "the Nobel prize of science writing".[56] The book was also the recipient of the 2017 Phi Beta Kappa Society Book Award in Science.[57]

Criticism and response

In his 2016 article 'Same but different' in The New Yorker, Mukherjee attributed the most important genetic functions to epigenetic factors (such as histone modification and DNA methylation). Giving an analogy of his mother and her twin sister, he explains:

Chance events—injuries, infections, infatuations; the haunting trill of that particular nocturne—impinge on one twin and not on the other. Genes are turned on and off in response to these events, as epigenetic marks are gradually layered above genes, etching the genome with its own scars, calluses, and freckles.[58]

The article, an excerpt from the chapter "The First Derivative of Identity" of his book The Gene: An Intimate History,[59] was critiqued by geneticists such as Mark Ptashne, at the Memorial Sloan Kettering Cancer Center, and John Greally, at the Albert Einstein College of Medicine, because of over emphasis on histone modification and DNA methylation, while overlooking other important factors. They commented that these two processes have only minor influences in overall gene function. Steven Henikoff, at the Fred Hutchinson Cancer Research Center, opined that, "Mukherjee seemed not to realize that transcription factors occupy the top of the hierarchy of epigenetic information," and said, "histone modifications at most act as cogs in the machinery."[60] It is now generally believed that histone modification and DNA methylations are major factors of epigenetic functions, aging and certain diseases,[61] and with an ability to influence transcription factors.[62] However, they contribute little to development.[63][64] In response, Mukherjee did admit that omission of transcription factors "was an error" on his part.[60]

Mukherjee also criticises the IQ test as a measure of intelligence, and endorses the theory of multiple intelligences (introduced by Howard Gardner) over general intelligence. He argues that the results of IQ tests for determining general intelligence do not represent intelligence in the real world. Reviewing the book in The Spectator, Stuart Ritchie, a psychologist at the University of Edinburgh, remarked that Gardner's theory is "debunked" and that "general intelligence is probably the most well-replicated phenomenon in all of psychological science."[65]

Mukherjee also wrongly stated that "classical Darwinian evolution is that genes do not retain an organism's experiences in a permanently heritable manner... Darwin discredited that model [of Lamarck]." But Darwin had no idea of the gene—the concept of which was established only in the 20th century. Science writer Razib Khan noted this erroneous conception, and explained that "Darwin worked in the pre-genetic era... he himself was quite open to Lamarckianism in some cases."[66]

List of books published
  • 2010: The Emperor of All Maladies: A Biography of Cancer (ISBN 978-0-00-725092-9).[67]
  • 2015: The Laws of Medicine: Field Notes from an Uncertain Science (ISBN 978-1-4711-4185-0).[68]
  • 2016: The Gene: An Intimate History (ISBN 978-1476733500).[69]

Awards and honours
Siddhartha Mukherjee receiving Padma Shri Award from Pranab Mukherjee, President of India, at Rashtrapati Bhavan in New Delhi on 26 April 2014.

Mukherjee has won several awards including:

Personal life

Mukherjee lives in New York and is married to artist Sarah Sze, winner of a MacArthur "Genius" grant and representative of the United States to the 2013 Venice Biennale. They have two daughters, Leela and Aria.[83]

See also

References
  1. Rogers, Kara. "Siddhartha Mukherjee: Indian-born American physician, scientist, and writer". www.britannica.com. Encyclopædia Britannica, Inc. Retrieved 8 May 2017.
  2. "Pulitzer for US-Indian Siddhartha Mukherjee's book". BBC. 19 April 2011. Retrieved 25 June 2018.
  3. Flood, A. (1 December 2011). "Biography of cancer wins Guardian First Book award". The Guardian. Retrieved 25 June 2018.
  4. Cruz, Gilbert (17 August 2011). "All-TIME 100 Nonfiction Books". Time. Retrieved 28 September 2014.
  5. "The New York Times Best Sellers". The New York Times. 12 June 2016. Retrieved 25 June 2018.
  6. New York Times Sunday Book Review Editorial Staff (24 November 2010). "100 Notable Books of 2010". New York Times Magazine. Retrieved 28 September 2014.
  7. "Siddhartha Mukherjee, author-doctor, is guest at Express Adda today". The Indian Express. 27 March 2018. Retrieved 25 June 2018.
  8. Mackovich, Ron (8 March 2018). "Renowned oncologist Siddhartha Mukherjee named USC's 2018 commencement speaker". USC News. Retrieved 25 June 2018.
  9. Solomon, Andrew (22 February 2018). "Literature about medicine may be all that can save us". The Guardian. Retrieved 25 June 2018.
  10. "Siddhartha Mukherjee, MD, DPhil". Columbia Stem Cell Initiative (CSCI). Retrieved 25 June 2018.
  11. "Indo-American Siddhartha Mukherjee calls Padma Shri a great Honor". IANS. Biharprabha News. Retrieved 27 January 2014.
  12. http://phibetakappa.tumblr.com/post/163177576378/the-gene-by-siddhartha-mukherjee
  13. Mukherjee, Siddhartha (1997). The processing and presentation of viral antigens (DPhil thesis). University of Oxford. OCLC 43182774.
  14. "Medical Alumnus Wins Pulitzer Prize for Nonfiction". Harvard Magazine. 18 April 2011. Retrieved 7 January 2017.
  15. Levin, Ann. "Cancer's Biographer". The Record (Columbia University). Retrieved 6 September 2011.
  16. "Siddhartha Mukherjee, MD, DPhil". www.columbiadoctors.org. Columbia University. Retrieved 8 May 2017.
  17. McGrath, Charles (8 November 2010). "How Cancer Acquired Its Own Biographer". The New York Times. Retrieved 6 September 2011.
  18. "Siddhartha Mukherjee, MD, DPhil". NewYork-Presbyterian. Retrieved 10 May 2017.
  19. "Siddhartha Mukherjee, M.D., Ph.D." ACT for NIH. Retrieved 25 June 2018.
  20. "Physician's Profile: Siddhartha Mukherjee, MD, DPhil". Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center. Retrieved 27 June 2018.
  21. Mukherjee, Siddhartha (2015). "Soon we'll cure diseases with a cell, not a pill". Ted Talks. Retrieved 26 June 2018.
  22. Morrison, Sean J.; Scadden, David T. (2014). "The bone marrow niche for haematopoietic stem cells". Nature. 505 (7483): 327–334. doi:10.1038/nature12984. PMC 4514480. PMID 24429631.
  23. Raaijmakers, Marc H. G. P.; Mukherjee, Siddhartha; Guo, Shangqin; Zhang, Siyi; Kobayashi, Tatsuya; Schoonmaker, Jesse A.; Ebert, Benjamin L.; Al-Shahrour, Fatima; et al. (2010). "Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia". Nature. 464 (7290): 852–857. doi:10.1038/nature08851. PMC 3422863. PMID 20305640.
  24. "Insight". The Rockefeller University. Retrieved 8 May 2017.
  25. "Siddhartha Mukherjee, MD, DPhil". ColumbiaDoctors. Columbia University Medical Center. Retrieved 27 June 2018.
  26. Mukherjee, Siddhartha; Raje, Noopur; Schoonmaker, Jesse A.; Liu, Julie C.; Hideshima, Teru; Wein, Marc N.; Jones, Dallas C.; Vallet, Sonia; et al. (2008). "Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice". Journal of Clinical Investigation. 118 (2): 491–504. doi:10.1172/JCI33102. PMC 2213372. PMID 18219387.
  27. Raje, N; Hideshima, T; Mukherjee, S; Raab, M; Vallet, S; Chhetri, S; Cirstea, D; Pozzi, S; et al. (2009). "Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma". Leukemia. 23 (5): 961–970. doi:10.1038/leu.2008.378. PMID 19151776.
  28. Jones, M. D.; Liu, J. C.; Barthel, T. K.; Hussain, S.; Lovria, E.; Cheng, D.; Schoonmaker, J. A.; Mulay, S.; et al. (2010). "A Proteasome Inhibitor, Bortezomib, Inhibits Breast Cancer Growth and Reduces Osteolysis by Downregulating Metastatic Genes". Clinical Cancer Research. 16 (20): 4978–4989. doi:10.1158/1078-0432.CCR-09-3293. PMC 2955762. PMID 20843837.
  29. Sykes, David B.; Kfoury, Youmna S.; Mercier, François E.; Wawer, Mathias J.; Law, Jason M.; Haynes, Mark K.; Lewis, Timothy A.; Schajnovitz, Amir; et al. (2016). "Inhibition of Dihydroorotate Dehydrogenase Overcomes Differentiation Blockade in Acute Myeloid Leukemia". Cell. 167 (1): 171–186.e15. doi:10.1016/j.cell.2016.08.057. PMC 7360335. PMID 27641501.
  30. Bhagat, Tushar D.; Chen, Si; Bartenstein, Matthias; Barlowe, A. Trevor; Von Ahrens, Dagny; Choudhary, Gaurav S.; Tivnan, Patrick; Amin, Elianna; et al. (2017). "Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation". Cancer Research. 77 (18): 4846–4857. doi:10.1158/0008-5472.CAN-17-0282. PMC 5600853. PMID 28684528.
  31. Chen, X.; Takemoto, Y.; Deng, H.; Middelhoff, M.; Friedman, R. A.; Chu, T. H.; Churchill, M. J.; Ma, Y.; et al. (2017). "Histidine decarboxylase (HDC)-expressing granulocytic myeloid cells induce and recruit Foxp3+ regulatory T cells in murine colon cancer". OncoImmunology. 6 (3): e1290034. doi:10.1080/2162402X.2017.1290034. PMC 5384347. PMID 28405523.
  32. Vallet, S.; Mukherjee, S.; Vaghela, N.; Hideshima, T.; Fulciniti, M.; Pozzi, S.; Santo, L.; Cirstea, D.; et al. (2010). "Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease". Proceedings of the National Academy of Sciences. 107 (11): 5124–5129. doi:10.1073/pnas.0911929107. PMC 2841922. PMID 20194748.
  33. Dimopoulos, Meletios A; Goldschmidt, Hartmut; Niesvizky, Ruben; Joshua, Douglas; Chng, Wee-Joo; Oriol, Albert; Orlowski, Robert Z; Ludwig, Heinz; et al. (2017). "Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial". The Lancet Oncology. 18 (10): 1327–1337. doi:10.1016/S1470-2045(17)30578-8. PMID 28843768.
  34. Komrokji, Rami; Garcia-Manero, Guillermo; Ades, Lionel; Prebet, Thomas; Steensma, David P; Jurcic, Joseph G; Sekeres, Mikkael A; Berdeja, Jesus; et al. (2018). "Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial". The Lancet Haematology. 5 (2): e63–e72. doi:10.1016/S2352-3026(18)30002-4. PMID 29331635.
  35. Raaijmakers, Marc H. G. P.; Mukherjee, Siddhartha; Guo, Shangqin; Zhang, Siyi; Kobayashi, Tatsuya; Schoonmaker, Jesse A.; Ebert, Benjamin L.; Al-Shahrour, Fatima; et al. (2010). "Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia". Nature. 464 (7290): 852–857. doi:10.1038/nature08851. PMC 3422863. PMID 20305640.
  36. Guryanova, O A; Lieu, Y K; Garrett-Bakelman, F E; Spitzer, B; Glass, J L; Shank, K; Martinez, A B V; Rivera, S A; et al. (29 December 2015). "Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells". Leukemia. 30 (5): 1133–1142. doi:10.1038/leu.2015.358. PMC 4856586. PMID 26710888.
  37. Worthley, Daniel L.; Churchill, Michael; Compton, Jocelyn T.; Tailor, Yagnesh; Rao, Meenakshi; Si, Yiling; Levin, Daniel; Schwartz, Matthew G.; Uygur, Aysu; et al. (2015). "Gremlin 1 Identifies a Skeletal Stem Cell with Bone, Cartilage, and Reticular Stromal Potential". Cell. 160 (1–2): 269–284. doi:10.1016/j.cell.2014.11.042. PMC 4436082. PMID 25594183.
  38. McGonagle, Dennis; Jones, Elena A. (2015). "A new in vivo stem cell model for regenerative rheumatology". Nature Reviews Rheumatology. 11 (4): 200–201. doi:10.1038/nrrheum.2015.21. PMID 25734973. S2CID 29933567.
  39. Kassem, Moustapha; Bianco, Paolo (2015). "Skeletal Stem Cells in Space and Time". Cell. 160 (1–2): 17–19. doi:10.1016/j.cell.2014.12.034. PMID 25594172.
  40. Osório, Joana (2015). "Back to the origins—identifying the skeletal stem cell". Nature Reviews Endocrinology. 11 (3): 132. doi:10.1038/nrendo.2015.14. PMID 25645704. S2CID 52861069.
  41. Lannagan, Tamsin R M; Lee, Young K; Wang, Tongtong; Roper, Jatin; Bettington, Mark L; Fennell, Lochlan; Vrbanac, Laura; Jonavicius, Lisa; et al. (2018). "Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis". Gut. 68 (4): gutjnl–2017–315920. doi:10.1136/gutjnl-2017-315920. PMC 6192855. PMID 29666172.
  42. Hammoudi, Naima; Riaz Ahmed, Kausar Begam; Garcia-Prieto, Celia; Huang, Peng (2011). "Metabolic alterations in cancer cells and therapeutic implications". Chinese Journal of Cancer. 30 (8): 508–525. doi:10.5732/cjc.011.10267. PMC 4013402. PMID 21801600.
  43. Cantley, Lewis C. (2018). "Abstract KN01: Keynote Lecture: PI 3-kinase links obesity, insulin resistance, and cancer". Molecular Cancer Therapeutics. 17 (1): KN01. doi:10.1158/1535-7163.TARG-17-KN01.
  44. Craig, Jessica (10 May 2016). "CAR T-cell start-up launched". mdedge.com. Frontline Medical Communications Inc. Retrieved 26 June 2018.
  45. "About VOR". Vor Biopharma. Retrieved 26 June 2018.
  46. Walters, Jenny (18 May 2018). "Beyond B cells". Biocentury. Retrieved 26 June 2018.
  47. Mukherjee, Siddhartha (16 November 2010). The Emperor of All Maladies: A Biography of Cancer. Simon and Schuster. ISBN 978-1-4391-0795-9. Retrieved 6 September 2011.
  48. Roy, Amit (10 November 2009). "Chronicler of cancer, emperor of maladies". The Telegraph – Calcutta (Kolkata). Retrieved 6 September 2011.
  49. "The 2011 Pulitzer Prize Winners: General Non-Fiction". The Pulitzer Prizes. Retrieved 12 November 2013.
  50. "The Top 10 Everything of 2010". Time. 9 December 2010. Retrieved 6 September 2011.
  51. "The 10 Best Books of 2010". The New York Times. 1 December 2010. Retrieved 6 September 2011.
  52. Sehgal, Parul. "The Emperor of All Maladies (Book Review)". Oprah.com. Retrieved 6 September 2011.
  53. "All Past National Book Critics Circle Award Winners and Finalists". National Book Critics Circle. Retrieved 25 June 2018.
  54. Genzlinger, Neil (27 March 2015). "Review: In 'Cancer: The Emperor of All Maladies,' Battling an Opportunistic Killer". New York Times. Retrieved 31 March 2015.
  55. "Siddhartha Mukherjee's Touching Cancer Docu Nominated at the Emmys". The Quint. 24 August 2015. Retrieved 8 May 2017.
  56. Flood, Alison (4 August 2016). "Bill Bryson hails 'thrilling' Royal Society science book prize shortlist". The Guardian. ISSN 0261-3077. Retrieved 22 September 2016.
  57. DeSimone, Bailey (1 December 2017). "The Key Reporter - Siddhartha Mukherjee". www.keyreporter.org. The Phi Beta Kappa Society. The Key Reporter.
  58. Mukherjee, S. (2 May 2016). "Same but different". The New Yorker. Retrieved 8 May 2017.
  59. Mukherjee, S. (17 May 2016). The Gene: An Intimate History. UK: Penguin. ISBN 978-1-4767-3352-4.
  60. Woolston, Chris (2016). "Researcher under fire for New Yorker epigenetics article". Nature. 533 (7603): 295. doi:10.1038/533295f.
  61. López, V.; Fernández, A.F.; Fraga, M.F. (2017). "The role of 5-hydroxymethylcytosine in development, aging and age-related diseases". Ageing Research Reviews. Online: 28–38. doi:10.1016/j.arr.2017.05.002. PMID 28499883. S2CID 3748806.
  62. Yin, Yimeng; Morgunova, Ekaterina; Jolma, Arttu; Kaasinen, Eevi; Sahu, Biswajyoti; Khund-Sayeed, Syed; Das, Pratyush K.; Kivioja, Teemu; et al. (2017). "Impact of cytosine methylation on DNA binding specificities of human transcription factors". Science. 356 (6337): eaaj2239. doi:10.1126/science.aaj2239. PMID 28473536. S2CID 206653898.
  63. Edwards, John R.; Yarychkivska, Olya; Boulard, Mathieu; Bestor, Timothy H. (2017). "DNA methylation and DNA methyltransferases". Epigenetics & Chromatin. 10 (1): 23. doi:10.1186/s13072-017-0130-8. PMC 5422929. PMID 28503201.
  64. Shen, Hongjie; Xu, Wenqi; Lan, Fei (2017). "Histone lysine demethylases in mammalian embryonic development". Experimental & Molecular Medicine. 49 (4): e325. doi:10.1038/emm.2017.57. PMC 6130211. PMID 28450736.
  65. Ritchie, Stuart (28 May 2016). "How Siddhartha Mukherjee gets it wrong on IQ, sexuality and epigenetics". The Spectator. Retrieved 8 May 2017.
  66. Khan, Razib (28 April 2016). "The New Yorker Has Fact-Checkers, They Should Use Them". The Unz Review: An Alternative Media Selection. Retrieved 8 May 2017.
  67. Suh, Dong Hoon (October 2012). "Book Review: The emperor of all maladies: a biography of cancer by Siddhartha Mukherjee". J Gynecol Oncol. 23 (4): 291–292. doi:10.3802/jgo.2012.23.4.291. PMC 3469866.
  68. Siddhartha Mukherjee, The Laws of Medicine: Field Notes from an Uncertain Science, Simon & Schuster, 2015 (page visited on 10 December 2015).
  69. James Gleick, "The Gene, by Siddhartha Mukherjee, New York Times May 15, 2016 review
  70. Los Angeles Times Book Review Editorial Staff (2011). "2010 Los Angeles Times Book Prizes Winners & Finalists". Los Angeles Times Festival of Books. Retrieved 28 September 2014.
  71. "PEN/E. O. Wilson Literary Science Writing Award Winners". Pen America. Retrieved 25 June 2018.
  72. "Annual Cancer Leadership Awards Reception". Friends of Cancer Research. Retrieved 25 June 2018.
  73. "The 2011 TIME 100 Poll Results". Time. Retrieved 25 June 2018.
  74. Bourke, Joanna (2011). "2011 Wellcome Trust Book Prize shortlist". The Lancet. 378 (9801): 1454. doi:10.1016/S0140-6736(11)61585-7. S2CID 54401744.
  75. Farrington, Roger (25 April 2012). "The Associates of the Boston Public Library's "Literary Lights" Dinner". Wellesley Patch. Retrieved 25 June 2018.
  76. "Padma Awards Announced". Press Information Bureau, Ministry of Home Affairs, Government of India. 25 January 2014. Archived from the original on 8 February 2014. Retrieved 26 January 2014.
  77. "Shortlist for The Royal Society Insight Investment Science Book Prize 2016 unveiled". The Royal Society. 6 August 2016. Retrieved 17 May 2017.
  78. "Nobel laureate Svetlana Alexievich heads longlist for UK's top nonfiction award". 20 September 2016.
  79. "10 Best Books of 2016". The Washington Post. 17 November 2016. Retrieved 17 May 2017.
  80. GrrlScientist (15 March 2017). "Wellcome Book Prize 2017 Shortlist Revealed".
  81. NUI (31 May 2018). "Conferring of NUI degrees in RCSI, Dublin – May 2018". National University of Ireland. Retrieved 27 June 2018.
  82. Mackovich, Ron (6 April 2018). "USC announces five honorary degree recipients for 2018 commencement". USC News. Retrieved 27 June 2018.
  83. Kazanjian, Dodie (11 May 2016). "Meet the Most Brilliant Couple in Town". Vogue.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.